Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Complex care and contradictions of choice in the safety net.

Van Natta M, Burke NJ, Yen IH, Rubin S, Fleming MD, Thompson-Lastad A, Shim JK.

Sociol Health Illn. 2018 Feb 8. doi: 10.1111/1467-9566.12661. [Epub ahead of print]

PMID:
29424102
2.

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.

Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK, Ho J, Miller AR, Cook RW, Covington KR, Meldi-Plasseraud K, Middlebrook B, Kaminester LH, Greisinger A, Estrada SI, Pariser DM, Cranmer LD, Messina JL, Vetto JT, Wayne JD, Delman KA, Lawson DH, Gerami P.

BMC Cancer. 2018 Feb 5;18(1):130. doi: 10.1186/s12885-018-4016-3.

3.

Endoscopic versus open great saphenous vein harvesting for femoral to popliteal artery bypass.

Mirza AK, Stauffer K, Fleming MD, De Martino R, Oderich G, Kalra M, Gloviczki P, Bower T.

J Vasc Surg. 2017 Nov 1. pii: S0741-5214(17)32219-X. doi: 10.1016/j.jvs.2017.08.084. [Epub ahead of print]

PMID:
29102747
4.

Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.

Carapito R, Konantz M, Paillard C, Miao Z, Pichot A, Leduc MS, Yang Y, Bergstrom KL, Mahoney DH, Shardy DL, Alsaleh G, Naegely L, Kolmer A, Paul N, Hanauer A, Rolli V, Müller JS, Alghisi E, Sauteur L, Macquin C, Morlon A, Sancho CS, Amati-Bonneau P, Procaccio V, Mosca-Boidron AL, Marle N, Osmani N, Lefebvre O, Goetz JG, Unal S, Akarsu NA, Radosavljevic M, Chenard MP, Rialland F, Grain A, Béné MC, Eveillard M, Vincent M, Guy J, Faivre L, Thauvin-Robinet C, Thevenon J, Myers K, Fleming MD, Shimamura A, Bottollier-Lemallaz E, Westhof E, Lengerke C, Isidor B, Bahram S.

J Clin Invest. 2017 Nov 1;127(11):4090-4103. doi: 10.1172/JCI92876. Epub 2017 Oct 3.

5.

Response to commentary, "Trauma and the structuring of complex care: Back to the settlements?" by Elizabeth Bowen.

Thompson-Lastad A, Yen IH, Fleming MD, Van Natta M, Rubin S, Shim JK, Burke NJ.

Soc Sci Med. 2017 Nov;192:28-29. doi: 10.1016/j.socscimed.2017.09.023. Epub 2017 Sep 21. No abstract available.

PMID:
28957781
6.

UBE2O remodels the proteome during terminal erythroid differentiation.

Nguyen AT, Prado MA, Schmidt PJ, Sendamarai AK, Wilson-Grady JT, Min M, Campagna DR, Tian G, Shi Y, Dederer V, Kawan M, Kuehnle N, Paulo JA, Yao Y, Weiss MJ, Justice MJ, Gygi SP, Fleming MD, Finley D.

Science. 2017 Aug 4;357(6350). pii: eaan0218. doi: 10.1126/science.aan0218.

7.

Neoadjuvant Talimogene Laherparepvec for the Treatment of Metastatic Melanoma.

Stiles ZE, Fleming MD, Luce EA, Deneve JL.

Am Surg. 2017 Jul 1;83(7):266-268. No abstract available.

PMID:
28738934
8.

Management of refractory chylous ascites with peritoneovenous shunts.

Huang Y, Gloviczki P, Duncan AA, Fleming MD, Driscoll DJ, Kalra M, Oderich GS, Bower TC.

J Vasc Surg Venous Lymphat Disord. 2017 Jul;5(4):538-546. doi: 10.1016/j.jvsv.2017.03.011. Epub 2017 May 9.

PMID:
28623993
9.

Defining trauma in complex care management: Safety-net providers' perspectives on structural vulnerability and time.

Thompson-Lastad A, Yen IH, Fleming MD, Van Natta M, Rubin S, Shim JK, Burke NJ.

Soc Sci Med. 2017 Aug;186:104-112. doi: 10.1016/j.socscimed.2017.06.003. Epub 2017 Jun 12.

PMID:
28618290
10.

Impact of body mass index on the short-term outcomes of resected gastrointestinal stromal tumors.

Stiles ZE, Rist TM, Dickson PV, Glazer ES, Fleming MD, Shibata D, Deneve JL.

J Surg Res. 2017 Sep;217:123-130. doi: 10.1016/j.jss.2017.05.010. Epub 2017 May 10.

PMID:
28595816
11.

Patient engagement at the margins: Health care providers' assessments of engagement and the structural determinants of health in the safety-net.

Fleming MD, Shim JK, Yen IH, Thompson-Lastad A, Rubin S, Van Natta M, Burke NJ.

Soc Sci Med. 2017 Jun;183:11-18. doi: 10.1016/j.socscimed.2017.04.028. Epub 2017 Apr 20.

12.

Outcome of peripheral venous reconstructions during tumor resection.

Sun PY, Fleming MD, Stauffer K, Kalra M, Oderich G, Bower T, Gloviczki P, DeMartino RR.

J Vasc Surg Venous Lymphat Disord. 2017 Mar;5(2):185-193. doi: 10.1016/j.jvsv.2016.10.077.

PMID:
28214485
13.

Maximal aortic diameter affects outcome after endovascular repair of abdominal aortic aneurysms.

Huang Y, Gloviczki P, Duncan AA, Kalra M, Oderich GS, Fleming MD, Harmsen WS, Bower TC.

J Vasc Surg. 2017 May;65(5):1313-1322.e4. doi: 10.1016/j.jvs.2016.10.093. Epub 2016 Dec 27.

PMID:
28034585
14.

Ringed sideroblasts in β-thalassemia.

Cattivelli K, Campagna DR, Schmitz-Abe K, Heeney MM, Yaish HM, Caruso Brown AE, Kearney S, Walkovich K, Markianos K, Fleming MD, Neufeld EJ.

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26324. Epub 2016 Nov 3.

15.

Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.

Obeng EA, Chappell RJ, Seiler M, Chen MC, Campagna DR, Schmidt PJ, Schneider RK, Lord AM, Wang L, Gambe RG, McConkey ME, Ali AM, Raza A, Yu L, Buonamici S, Smith PG, Mullally A, Wu CJ, Fleming MD, Ebert BL.

Cancer Cell. 2016 Sep 12;30(3):404-417. doi: 10.1016/j.ccell.2016.08.006.

16.

A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding.

Boyraz B, Bellomo CM, Fleming MD, Cutler CS, Agarwal S.

Blood. 2016 Oct 20;128(16):2089-2092. doi: 10.1182/blood-2016-04-710160. Epub 2016 Sep 1. No abstract available.

17.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Fields RC, Fleming MD, Gastman B, Gonzalez R, Guild V, Johnson D, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Aug;14(8):945-58.

PMID:
27496110
18.

A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia.

Lichtenstein DA, Crispin AW, Sendamarai AK, Campagna DR, Schmitz-Abe K, Sousa CM, Kafina MD, Schmidt PJ, Niemeyer CM, Porter J, May A, Patnaik MM, Heeney MM, Kimmelman A, Bottomley SS, Paw BH, Markianos K, Fleming MD.

Blood. 2016 Oct 13;128(15):1913-1917. Epub 2016 Aug 3.

19.

Impact of Chronic Kidney Disease on Clinical Outcomes of Endovascular Treatment for Femoropopliteal Arterial Disease.

Heideman PP, Rajebi MR, McKusick MA, Bjarnason H, Oderich GS, Friese JL, Fleming MD, Stockland AH, Harmsen WS, Mandrekar J, Misra S.

J Vasc Interv Radiol. 2016 Aug;27(8):1204-14. doi: 10.1016/j.jvir.2016.04.036. Epub 2016 Jun 16.

20.

Impact of femoropopliteal endovascular interventions on subsequent open bypass.

Gifford SM, Fleming MD, Mendes BC, Stauffer KC, De Martino RR, Oderich GS, Gloviczki P, Bower TC.

J Vasc Surg. 2016 Sep;64(3):623-8. doi: 10.1016/j.jvs.2016.03.467. Epub 2016 Jun 8.

PMID:
27288105
21.

The placenta: the forgotten essential organ of iron transport.

Cao C, Fleming MD.

Nutr Rev. 2016 Jul;74(7):421-31. doi: 10.1093/nutrit/nuw009. Epub 2016 May 31. Review.

22.

Pseudouridine synthase 1 deficient mice, a model for Mitochondrial Myopathy with Sideroblastic Anemia, exhibit muscle morphology and physiology alterations.

Mangum JE, Hardee JP, Fix DK, Puppa MJ, Elkes J, Altomare D, Bykhovskaya Y, Campagna DR, Schmidt PJ, Sendamarai AK, Lidov HG, Barlow SC, Fischel-Ghodsian N, Fleming MD, Carson JA, Patton JR.

Sci Rep. 2016 May 20;6:26202. doi: 10.1038/srep26202.

23.

Effects of Testosterone on Erythropoiesis in a Female Mouse Model of Anemia of Inflammation.

Guo W, Schmidt PJ, Fleming MD, Bhasin S.

Endocrinology. 2016 Jul;157(7):2937-46. doi: 10.1210/en.2016-1150. Epub 2016 Apr 13.

24.

Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, Daniels GA, DiMaio D, Ernstoff M, Fields RC, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS Jr, Joseph RW, Lange JR, Martini MC, Materin MA, Olszanski AJ, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Torres-Roca JF, Trisal V, Urist MM, McMillian N, Engh A.

J Natl Compr Canc Netw. 2016 Apr;14(4):450-73.

PMID:
27059193
25.

Open surgical removal of retained and dislodged inferior vena cava filters.

Rana MA, Gloviczki P, Kalra M, Bjarnason H, Huang Y, Fleming MD.

J Vasc Surg Venous Lymphat Disord. 2015 Apr;3(2):201-6. doi: 10.1016/j.jvsv.2014.11.007. Epub 2015 Mar 13.

PMID:
26993841
26.

The natural history and outcomes for thoracic and abdominal penetrating aortic ulcers.

Gifford SM, Duncan AA, Greiten LE, Gloviczki P, Oderich GS, Kalra M, Fleming MD, Bower TC.

J Vasc Surg. 2016 May;63(5):1182-8. doi: 10.1016/j.jvs.2015.11.050. Epub 2016 Feb 3.

PMID:
26852004
27.

A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.

Jabara HH, Boyden SE, Chou J, Ramesh N, Massaad MJ, Benson H, Bainter W, Fraulino D, Rahimov F, Sieff C, Liu ZJ, Alshemmari SH, Al-Ramadi BK, Al-Dhekri H, Arnaout R, Abu-Shukair M, Vatsayan A, Silver E, Ahuja S, Davies EG, Sola-Visner M, Ohsumi TK, Andrews NC, Notarangelo LD, Fleming MD, Al-Herz W, Kunkel LM, Geha RS.

Nat Genet. 2016 Jan;48(1):74-8. doi: 10.1038/ng.3465. Epub 2015 Dec 7.

28.

LARS2 Variants Associated with Hydrops, Lactic Acidosis, Sideroblastic Anemia, and Multisystem Failure.

Riley LG, Rudinger-Thirion J, Schmitz-Abe K, Thorburn DR, Davis RL, Teo J, Arbuckle S, Cooper ST, Campagna DR, Frugier M, Markianos K, Sue CM, Fleming MD, Christodoulou J.

JIMD Rep. 2016;28:49-57. Epub 2015 Nov 5.

29.

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.

Schmitz-Abe K, Ciesielski SJ, Schmidt PJ, Campagna DR, Rahimov F, Schilke BA, Cuijpers M, Rieneck K, Lausen B, Linenberger ML, Sendamarai AK, Guo C, Hofmann I, Newburger PE, Matthews D, Shimamura A, Snijders PJ, Towne MC, Niemeyer CM, Watson HG, Dziegiel MH, Heeney MM, May A, Bottomley SS, Swinkels DW, Markianos K, Craig EA, Fleming MD.

Blood. 2015 Dec 17;126(25):2734-8. doi: 10.1182/blood-2015-09-659854. Epub 2015 Oct 21.

30.

Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.

Latour C, Besson-Fournier C, Meynard D, Silvestri L, Gourbeyre O, Aguilar-Martinez P, Schmidt PJ, Fleming MD, Roth MP, Coppin H.

Hepatology. 2016 Jan;63(1):126-37. doi: 10.1002/hep.28254. Epub 2015 Nov 12.

PMID:
26406355
31.

Complicated and Advanced Atherosclerosis in a Young Woman With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Success and Challenges of BCR/ABL1-Targeted Cancer Therapy.

Herrmann J, Bell MR, Warren RL, Lerman A, Fleming MD, Patnaik M.

Mayo Clin Proc. 2015 Aug;90(8):1167-8. doi: 10.1016/j.mayocp.2015.05.013. No abstract available.

PMID:
26250733
32.

The ins and outs of erythroid heme transport.

Cao C, Fleming MD.

Haematologica. 2015 Jun;100(6):703. doi: 10.3324/haematol.2015.127886. No abstract available.

33.

Severe combined immunodeficiency (SCID) presenting with neonatal aplastic anemia.

Scott A, Glover J, Skoda-Smith S, Torgerson TR, Xu M, Burroughs LM, Woolfrey AE, Fleming MD, Shimamura A.

Pediatr Blood Cancer. 2015 Nov;62(11):2047-9. doi: 10.1002/pbc.25587. Epub 2015 May 22.

34.

Surgical treatment of popliteal venous aneurysms.

Johnstone JK, Fleming MD, Gloviczki P, Stone W, Kalra M, Oderich GS, Duncan AA, De Martino RR, Bower TC.

Ann Vasc Surg. 2015 Aug;29(6):1084-9. doi: 10.1016/j.avsg.2015.02.009. Epub 2015 May 22.

PMID:
26009475
35.

Outcome after open and endovascular repairs of abdominal aortic aneurysms in matched cohorts using propensity score modeling.

Huang Y, Gloviczki P, Oderich GS, Duncan AA, Kalra M, Fleming MD, Harmsen WS, Bower TC.

J Vasc Surg. 2015 Aug;62(2):304-11.e2. doi: 10.1016/j.jvs.2015.02.039. Epub 2015 May 2.

36.

Operative interventions for extrahepatic portomesenteric venous aneurysms and long-term outcomes.

Fleming MD, Lall P, Nagorney DM, Gloviczki P, Kalra M, Duncan A, Oderich G, Toomey B, Bower TC.

Ann Vasc Surg. 2015;29(4):654-60. doi: 10.1016/j.avsg.2015.01.029. Epub 2015 Mar 11.

PMID:
25770384
37.

Genome-wide association study follow-up identifies cyclin A2 as a regulator of the transition through cytokinesis during terminal erythropoiesis.

Ludwig LS, Cho H, Wakabayashi A, Eng JC, Ulirsch JC, Fleming MD, Lodish HF, Sankaran VG.

Am J Hematol. 2015 May;90(5):386-91. doi: 10.1002/ajh.23952. Epub 2015 Feb 5.

38.

Clinical presentation, comorbidities, and age but not female gender predict survival after endovascular repair of abdominal aortic aneurysm.

Gloviczki P, Huang Y, Oderich GS, Duncan AA, Kalra M, Fleming MD, Harmsen WS, Bower TC.

J Vasc Surg. 2015 Apr;61(4):853-61.e2. doi: 10.1016/j.jvs.2014.12.004. Epub 2015 Jan 13.

39.

Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictors.

Forester CM, Sartain SE, Guo D, Harris MH, Weinberg OK, Fleming MD, London WB, Williams DA, Hofmann I.

Am J Hematol. 2015 Apr;90(4):320-6. doi: 10.1002/ajh.23937. Epub 2015 Mar 2.

40.

Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia.

Schmidt PJ, Racie T, Westerman M, Fitzgerald K, Butler JS, Fleming MD.

Am J Hematol. 2015 Apr;90(4):310-3. doi: 10.1002/ajh.23934.

41.

A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.

Gutschow P, Schmidt PJ, Han H, Ostland V, Bartnikas TB, Pettiglio MA, Herrera C, Butler JS, Nemeth E, Ganz T, Fleming MD, Westerman M.

Haematologica. 2015 Feb;100(2):167-77. doi: 10.3324/haematol.2014.116723. Epub 2014 Nov 25.

42.

The evolving role of surgery for gastric lymphoma: from curative resection to surgical management of complications.

Paulus EM, Fleming MD, Hendrix AA, Deneve JL, Dickson PV, Mathew A, Martin MG, Munene G.

Am Surg. 2014 Nov;80(11):E322-4. No abstract available.

PMID:
25347493
43.

Reflux in the below-knee great saphenous vein can be safely treated with endovenous ablation.

Gifford SM, Kalra M, Gloviczki P, Duncan AA, Oderich GS, Fleming MD, Harmsen S, Bower TC.

J Vasc Surg Venous Lymphat Disord. 2014 Oct;2(4):397-402. doi: 10.1016/j.jvsv.2014.04.004. Epub 2014 May 24.

PMID:
26993545
44.

Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.

Zhang MY, Keel SB, Walsh T, Lee MK, Gulsuner S, Watts AC, Pritchard CC, Salipante SJ, Jeng MR, Hofmann I, Williams DA, Fleming MD, Abkowitz JL, King MC, Shimamura A.

Haematologica. 2015 Jan;100(1):42-8. doi: 10.3324/haematol.2014.113456. Epub 2014 Sep 19.

45.

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD).

Chakraborty PK, Schmitz-Abe K, Kennedy EK, Mamady H, Naas T, Durie D, Campagna DR, Lau A, Sendamarai AK, Wiseman DH, May A, Jolles S, Connor P, Powell C, Heeney MM, Giardina PJ, Klaassen RJ, Kannengiesser C, Thuret I, Thompson AA, Marques L, Hughes S, Bonney DK, Bottomley SS, Wynn RF, Laxer RM, Minniti CP, Moppett J, Bordon V, Geraghty M, Joyce PB, Markianos K, Rudner AD, Holcik M, Fleming MD.

Blood. 2014 Oct 30;124(18):2867-71. doi: 10.1182/blood-2014-08-591370. Epub 2014 Sep 5.

46.

The genomic landscape of pediatric Ewing sarcoma.

Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, Thorner AR, de Torres C, Lavarino C, Suñol M, McKenna A, Sivachenko A, Cibulskis K, Lawrence MS, Stojanov P, Rosenberg M, Ambrogio L, Auclair D, Seepo S, Blumenstiel B, DeFelice M, Imaz-Rosshandler I, Schwarz-Cruz Y Celis A, Rivera MN, Rodriguez-Galindo C, Fleming MD, Golub TR, Getz G, Mora J, Stegmaier K.

Cancer Discov. 2014 Nov;4(11):1326-41. doi: 10.1158/2159-8290.CD-13-1037. Epub 2014 Sep 3.

47.

Sideroblastic anemia: diagnosis and management.

Bottomley SS, Fleming MD.

Hematol Oncol Clin North Am. 2014 Aug;28(4):653-70, v. doi: 10.1016/j.hoc.2014.04.008. Epub 2014 Jun 2. Review.

PMID:
25064706
48.

Hereditary xerocytosis revisited.

Archer NM, Shmukler BE, Andolfo I, Vandorpe DH, Gnanasambandam R, Higgins JM, Rivera A, Fleming MD, Sachs F, Gottlieb PA, Iolascon A, Brugnara C, Alper SL, Nathan DG.

Am J Hematol. 2014 Dec;89(12):1142-6. doi: 10.1002/ajh.23799. Epub 2014 Jul 21. No abstract available.

49.

SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1.

Jeong SM, Lee J, Finley LW, Schmidt PJ, Fleming MD, Haigis MC.

Oncogene. 2015 Apr 16;34(16):2115-24. doi: 10.1038/onc.2014.124. Epub 2014 Jun 9.

50.

Melanoma, version 4.2014.

Coit DG, Thompson JA, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE 3rd, Daniels GA, Daud A, Dimaio D, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS Jr, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Martini MC, Olszanski AJ, Ross MI, Salama A, Swetter SM, Tanabe KK, Trisal V, Urist MM, McMillian NR, Ho M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 May;12(5):621-9.

PMID:
24812131

Supplemental Content

Loading ...
Support Center